Abstract: A plurality of stimulations is transmitted to tissue or other material using one or more transmitters. The plurality of signals associated with the excited tissue and the transmitted stimulations are measured. The measured signals are processed to generate field-related quantities, such as B1+ and/or MR signal maps. Field-related quantities are generated also from simulation, by calculating the one or more incident fields from a simulator model of the one or more transmitters and assuming a given distribution of electrical properties in the tissue or other material. Field-related quantities generated from simulation and experimental procedures are compared to each other. The assumed electrical properties distribution is updated and the procedure is repeated iteratively until the difference between simulated and experimental field-related quantities is smaller than a threshold.

Abstract: A chain belt for a continuously variable transmission which has a plurality of links and a plurality of coupling members connecting the plurality of links together. Each of the coupling members has an outer perimeter, a first end with a first prepared surface, and a second end with a second prepared surface. The prepared surfaces extend a depth from the outer perimeter of the coupling member. A first retaining member is fastened to the first prepared surface of the coupling members and a second retaining member is fastened to the second prepared surface of the coupling members. The first and second retaining members retain the plurality of links on the coupling members.

Abstract: The present invention provides methods for rapid forensic analysis of mitochondrial DNA and methods for characterizing heteroplasmy of mitochondrial DNA, which can be used to assess the progression of mitochondrial diseases.

Abstract: A chain guide and tensioning apparatus (10) for reducing friction and heat generated by said chain guide and tensioning apparatus (10) engaging a driven chain (16). A guide body (12) has an engagement surface (26) and a first aperture (54) extending through the guide body (12) and opening into the engagement surface (26). A guide face (14) at least partially overlays the engagement surface (26) and has a contact surface (44) configured to guide and tension the driven chain (16). A first recessed groove (46) is formed on the contact surface (44) and is in communication with at least one second aperture (48) extending through the guide face (14). The first aperture (54) is adaptable to receive and communicate oil from an oil source to the second aperture (48) and the first recessed groove (46) for reducing friction and heat from guiding and tensioning the driven chain (16).

Abstract: A jaw member includes an insulative member and a substrate. The substrate is formed as a single, integral component that has first and second side portions interconnected by a connector portion. The connector portion has first and second side portions that are interconnected by an arc-shaped portion. The connector portion is configured to be removed before use of the jaw member such that the first and second portions are electrically insulated from one another.

Abstract: A support structure includes strut members interconnected by articulated joints to form a series of linked scissor mechanisms. The structure can be remotely actuated to compress or expand its shape by adjusting the scissor joints within a range of motion. In particular, the support structure can be repositioned within the body lumen or retrieved from the lumen. The support structure can be employed to introduce and support a prosthetic valve within a body lumen.

Abstract: The invention provides and describes solid state 17?-ethynyl-androst-5-ene-3?,7?,17?-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol include Form I anhydrate and Form IV and Form V solvates. The invention further relates to solid and suspension formulations containing 17?-ethynyl-androst-5-ene-3?,7?,17?-triol in a described solid state form and use of the formulations to treat hyperglycemic conditions, such as type 2 diabetes and metabolic syndrome, and autoimmune conditions, such as rheumatoid arthritis, ulcerative colitis and type 1 diabetes, among other inflammation related conditions in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol and uses of such formulations in treating the described conditions.

Abstract: A method of manufacturing an end effector assembly including first and second energizable portions configured to supply energy to tissue is provided. The method includes forming a substrate including first and second portions interconnected by a connector portion. The substrate is formed as a single integrated component. The method further includes engaging the substrate with an insulative member, and removing the connector portion of the substrate to electrically insulate the first and second portions from one another.

Abstract: A method of underground watering utilizes a pouch-like container product made by joining a first sheet having SAP particles adhered to a first surface with a second sheet to form a container partially filled with such particles. The application of pressure, for example by passing the product through a roll nip, facilitates joining of the sheets and causes the particles to break through at least the one of the sheets to create an opening whereby free volume is created to permit the particles to expand when in contact with a liquid. The resultant product is used to collect, store, and dispense water-containing liquids into the soil for watering of agricultural plants, trees, and the like. A composite underground watering element is also included in an embodiment of the invention. The inventive products may also be used as a pad, including a propagation pad, to collect, store, and dispense water-containing-liquids into plant vessels to provide watering of plants.

Abstract: The invention provides and describes solid state 17?-ethynyl-androst-5-ene-3?,7?,17?-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol include Form I anhydrate and Form IV and Form V solvates. The invention further relates to solid and suspension formulations containing 17?-ethynyl-androst-5-ene-3?,7?,17?-triol in a described solid state form and use of the formulations to treat hyperglycemic conditions, such as type 2 diabetes and metabolic syndrome, and autoimmune conditions, such as rheumatoid arthritis, ulcerative colitis and type 1 diabetes, among other inflammation related conditions in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol and uses of such formulations in treating the described conditions.

Abstract: A support structure includes strut members interconnected by rotatable joints to form a series of linked scissor mechanisms. The structure can be remotely actuated to compress or expand its shape by adjusting the scissor joints within a range of motion. In particular, the support structure can be repositioned within the body lumen or retrieved from the lumen. The support structure can be employed to introduce and support a prosthetic valve within a body lumen.

Abstract: An endoluminal support structure includes strut members interconnected by swivel joints to form a series of linked scissor mechanisms. The structure can be remotely actuated to compress or expand its shape by adjusting the scissor joints within a range of motion. In particular, the support structure can be repositioned within the body lumen or retrieved from the lumen. The support structure can be employed to introduce and support a prosthetic valve within a body lumen.

Abstract: A model synthesizer generates a state-space model of a structure from frequency domain parameters of the structure using a selected number of significant eigenvalues of a matrix derived from the frequency-domain parameters such that the quality of the fit of the model is improved. A matrix of the frequency-domain parameters is reshaped so as to improve performance of determination of the fit quality. Passivity violations in the model can be removed via regularization and error control such that the fit quality of the model after removal of the passivity violations is within a specified tolerance. Cholesky factorization can improve the performance of passivity violation detection. This Abstract is provided for the sole purpose of complying with the Abstract requirement rules. This Abstract is submitted with the explicit understanding that it will not be used to interpret or to limit the scope or the meaning of the claims.

Abstract: A method of underground watering utilizes a pouch-like container product made by joining a first sheet having SAP particles adhered to a first surface with a second sheet to form a container partially filled with such particles. The application of pressure, for example by passing the product through a roll nip, facilitates joining of the sheets and causes the particles to break through at least the one of the sheets to create an opening whereby free volume is created to permit the particles to expand when in contact with a liquid. The resultant product is used to collect, store, and dispense water-containing liquids into the soil for watering of agricultural plants, trees, and the like. A composite underground watering element is also included in an embodiment of the invention. The inventive products may also be used as a pad, including a propagation pad, to collect, store, and dispense water-containing-liquids into plant vessels to provide watering of plants.

Abstract: The invention provides and describes solid state 17?-ethynyl-androst-5-ene-3?,7?,17?-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol include Form I anhydrate and Form IV and Form V solvates. The invention further relates to solid and suspension formulations containing 17?-ethynyl-androst-5-ene-3?,7?,17?-triol in a described solid state form and use of the formulations to treat hyperglycemic conditions, such as type 2 diabetes and metabolic syndrome, and autoimmune conditions, such as rheumatoid arthritis, ulcerative colitis and type 1 diabetes, among other inflammation related conditions in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-androst-5-ene-3?,7?,17?-triol and uses of such formulations in treating the described conditions.

Abstract: An endoluminal support structure includes strut members interconnected by swivel joints to form a series of linked scissor mechanisms. The structure can be remotely actuated to compress or expand its shape by adjusting the scissor joints within a range of motion. In particular, the support structure can be repositioned within the body lumen or retrieved from the lumen. The support structure can be employed to introduce and support a prosthetic valve within a body lumen.

Abstract: The invention provides and describes solid state 17?-ethynyl-5?-androstane-3?,17?-diol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates of 17?-ethynyl-5?-androstane-3?,17?-diol include Form III anhydrate and Form I solvate. The invention further relates to solid and suspension formulations containing 17?-ethynyl-5?-androstane-3?,17?-diol in a described solid state form and use of the formulations to treat cancers or precancers such as prostate cancer or breast cancer in subjects or human patients. The invention also relates to methods to make liquid formulations from solid state forms of 17?-ethynyl-5?-androstane-3?,17?-diol and uses of such formulations in treating the described conditions.

Abstract: The present technology relates generally to devices for electronically registering a surgical patient to his or her own pre-surgical image scan and associated systems and methods. In some embodiments, a surgical navigation registration device configured in accordance with the technology comprises a patient-specific inner surface having at least one contour element that matches a contour of an outer surface of at least a portion of the patient's anatomy, and at least three registration pathways incorporated in the device and configured to mate with the tip of a surgical navigation system tool, such as a pointer. The registration pathways may be configured to enable the tip of the surgical navigation system tool to directly contact the patient's anatomy or, alternatively, to prevent the tip of the surgical navigation system tool from directly contacting the patient's anatomy. The registration pathways may comprise channels that extend through the patient-specific inner surface.

Abstract: A support structure includes strut members interconnected by rotatable joints to form a series of linked scissor mechanisms. The structure can be remotely actuated to compress or expand its shape by adjusting the scissor joints within a range of motion. In particular, the support structure can be repositioned within the body lumen or retrieved from the lumen. The support structure can be employed to introduce and support a prosthetic valve within a body lumen.